clopidogrel ‐ how much, how soon and how longcardiovascular disease (CVD) ‐ cause of mortality in United StatesST‐elevation myocardial infarction (STEMIadenosine diphosphate (ADP) ‐ potent platelet aggregating factorClopidogrel for Reduction of Events During Observation (CREDO) trial...
Limited data exists on ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) managed by a well-organized cardiac care network in a metr... H Miyachi,A Takagi,K Miyauchi,... - 《Heart & Vessels》 被引量: 28发表: 2016年 A method for evaluating research syntheses: The...
low-density lipoprotein cholesterol; MI, myocardial infarction; PCI, percutaneous coronary intervention; PCSK9, proprotein convertase subtilisin/kexin type 9; RCA, right coronary artery; sc, subcutaneous; STEMI, ST-elevation myocardial infarction; TIA, transient ischaemic attack; TG, triglyceride; VHR, ...
aPrimary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for patients with ST-segment elevation myocardial infarction (STEMI). 主要经皮冠状干预 (PCI) 是首选的多次灌注液战略为有ST段海拔心肌梗塞STEMI的 (病人)。[translate] ...
doi:10.1016/j.annemergmed.2005.06.171N. ChawlaP. MoyerBoston STEMI InvestigatorsMosby, Inc.Annals of Emergency Medicine
• Hospital Stay: You’ll likely stay in the hospital for a few hours to overnight. If all goes well, you might go home the same day or the next day. Short-Term Recovery (First Week) • Activity: Rest and avoid heavy activities for the first few days. You can slowly get back ...
The prognostic value of TRPV1 channels in cancer often depends on the cancer type, stage and two-sided nature of [Ca2+]i elevation, which can either induce cancer cell apoptosis or enhance proliferation [233,234,235]. In breast cancer tissues and cell lines, TRPV1 mRNA is highly overexpre...
called ST-elevation myocardial infarction (STEMI), or partial blockage called non-ST elevation MI (NSTEMI). A person cannot tell the difference by symptoms, and the treatment is different: STEMI is treated with a stent, and NSTEMI treatment starts with anticoagulation and stent as a second line...
et al. Rituximab in patients with acute ST-elevation myocardial infarction (RITA-MI): an experimental medicine safety study. Cardiovasc. Res. 118, 872–882 (2021). Treatment with rituximab is safe when given in the acute ST-elevation MI setting and substantially alters circulating B cell ...
Also essential, but widely underestimated, factors like age [11], co-medication, comorbidity, and last but not least, gender have to be drawn into consideration as much as possible in animal studies before thinking about clinical trials.